Literature DB >> 9126270

Serine/threonine phosphorylation of orphan receptor hepatocyte nuclear factor 4.

G Jiang1, L Nepomuceno, Q Yang, F M Sladek.   

Abstract

We showed previously that hepatocyte nuclear factor 4 (HNF-4) defines a new subclass, Group IV, of nuclear receptors. In order to determine whether members of this subclass are phosphorylated, HNF-4 was overexpressed to high levels in insect cells using a baculovirus expression system. The baculovirus-expressed HNF-4 (HNF4.BV) was characterized and compared to HNF-4 overexpressed in transiently transfected mammalian (COS-7) cells (HNF4.COS). The results indicate that both HNF4.BV and HNF4.COS are phosphorylated although HNF4.BV was hypophosphorylated relative to HNF4.COS. Phosphoamino acid analysis showed that HNF-4 is phosphorylated mainly on serine and to a lesser extent on threonine residues. Phosphopeptide mapping revealed 13 phosphopeptides for HNF4.COS, only 9 of which were present in the HNF4.BV sample. DNA-binding studies also showed that HNF4.BV binds DNA with a lower specificity and affinity, as measured by the equilibrium dissociation constant (Kd), than does HNF4.COS. Partial proteolytic digestion experiments also revealed that HNF4.BV and HNF4.COS adopt somewhat different three-dimensional conformations. Since glycosylation of HNF4.BV was ruled out by a number of methods and since HNF-4 expressed in bacteria exhibited an even lower DNA-binding affinity than HNF4.BV, we propose that serine/theronine phosphorylation may play a role in the DNA-binding activity of HNF-4 and, therefore, possibly of other Group IV receptors as well.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9126270     DOI: 10.1006/abbi.1997.9914

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  28 in total

1.  Modulation of transcriptional activation and coactivator interaction by a splicing variation in the F domain of nuclear receptor hepatocyte nuclear factor 4alpha1.

Authors:  F M Sladek; M D Ruse; L Nepomuceno; S M Huang; M R Stallcup
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

Review 2.  Modulating nuclear receptor function: may the phos be with you.

Authors:  D Shao; M A Lazar
Journal:  J Clin Invest       Date:  1999-06       Impact factor: 14.808

Review 3.  Nuclear hormone receptors in diabetic nephropathy.

Authors:  Xiaoxin X Wang; Tao Jiang; Moshe Levi
Journal:  Nat Rev Nephrol       Date:  2010-04-27       Impact factor: 28.314

4.  Two functional modes of a nuclear receptor-recruited arginine methyltransferase in transcriptional activation.

Authors:  María J Barrero; Sohail Malik
Journal:  Mol Cell       Date:  2006-10-20       Impact factor: 17.970

5.  Phenobarbital regulates nuclear expression of HNF-4alpha in mouse and rat hepatocytes independent of CAR and PXR.

Authors:  Aaron W Bell; George K Michalopoulos
Journal:  Hepatology       Date:  2006-07       Impact factor: 17.425

Review 6.  Cell signaling and nuclear receptors: new opportunities for molecular pharmaceuticals in liver disease.

Authors:  Jeff L Staudinger; Kristin Lichti
Journal:  Mol Pharm       Date:  2007-12-27       Impact factor: 4.939

7.  Proposed mechanism for the stabilization of nuclear receptor DNA binding via protein dimerization.

Authors:  G Jiang; U Lee; F M Sladek
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

8.  Effects of hepatocyte nuclear factor-4alpha on the regulation of the hepatic acute phase response.

Authors:  Zhongyan Wang; Peter A Burke
Journal:  J Mol Biol       Date:  2007-05-24       Impact factor: 5.469

9.  Integrated approach for the identification of human hepatocyte nuclear factor 4alpha target genes using protein binding microarrays.

Authors:  Eugene Bolotin; Hailing Liao; Tuong Chi Ta; Chuhu Yang; Wendy Hwang-Verslues; Jane R Evans; Tao Jiang; Frances M Sladek
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425

10.  Hepatocyte nuclear factor 4 response to injury involves a rapid decrease in DNA binding and transactivation via a JAK2 signal transduction pathway.

Authors:  Xuemei Li; John Salisbury-Rowswell; Alan D Murdock; R Armour Forse; Peter A Burke
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.